Children with COVID-19-related inflammatory syndrome fully recover heart function

By 91ÊÓÆµ News

FatCamera/E+, Getty Images
(FatCamera/E+, Getty Images)

Children who develop COVID-19-related multisystem inflammatory syndrome, also called MIS-C, begin recovering in the first week of hospital discharge and fully recover normal heart function within three months, according to a new study.

The findings, published Wednesday in the , suggest children diagnosed with MIS-C can gradually resume playing competitive sports within three months.

"There is limited data at this time about how frequently and how long we should monitor heart function during the recovery state of MIS-C after the child leaves the hospital," study senior author Dr. Anirban Banerjee said in a news release. Banerjee is an attending cardiologist at the Cardiac Center with the Children's Hospital of Philadelphia.

"Given that MIS-C was identified last year as a result of the COVID-19 pandemic, treatment protocols have not yet been standardized, and follow-up care varies greatly, which may lead to confusion and anxiety among families of patients and their care team," Banerjee said. "Our research team hoped to provide some guidance and reduce the ambiguity on optimal care approaches, especially as it relates to sports participation."

MIS-C can appear in children four to six weeks after they've been exposed to COVID-19. It can cause inflammation in the heart, lungs, kidneys and gastrointestinal organs. About 80%-85% of MIS-C cases have involved the heart's left ventricle. The syndrome shares some characteristics with Kawasaki disease, a leading cause of acquired heart disease among young children in the U.S., with an average age of onset of 2. MIS-C, however, is associated with more profound inflammation.

In the new study, researchers detail heart damage and recovery during three to four months of follow-up in 60 children with MIS-C admitted to two Philadelphia hospitals between April 2020 and January 2021. None of the children, who were on average 10 years old, had been diagnosed with COVID-19 before onset of MIS-C symptoms.

Their results were compared with those of 60 children, on average 11.5 years old, who had no known exposure to COVID-19 or symptoms of the virus and whose hearts were structurally normal.

Among those exposed to COVID-19, about 81% lost some ability for the left ventricle to contract during the acute phase of the illness. But that function returned to normal within three to four months.

When first admitted to the hospital, 70% of children showed some signs of heart malfunction. But there were no lasting coronary artery abnormalities and within three months, all scans were normal.

"This study provides additional evidence that myocardial involvement is transient and may not lead to long-term abnormalities" in heart function, Dr. Kevin G. Friedman, a pediatric cardiologist at Boston Children's Hospital, said in the news release. He was not involved in the study.

"Although cardiac involvement in the acute stage of illness is common, it is reassuring that all patients recovered normal cardiac function within about one week," he said. "This data tells us that, fortunately, lasting heart injury is very uncommon in MIS-C."

Editor's note: This story was corrected Jan. 20, 2022. The percent of children showing some signs of heart malfunction when first admitted to the hospital was 70%, not 7%. Because of the rapidly evolving events surrounding the coronavirus, the facts and advice presented in this story may have changed since publication. Visit Heart.org for the latest coverage, and check with the Centers for Disease Control and Prevention and local health officials for the most recent guidance.

If you have questions or comments about this story, please email [email protected].


Noticias de 91ÊÓÆµ News

91ÊÓÆµ News abarca las enfermedades cardíacas, el ataque o derrame cerebral y los problemas de salud relacionados. No todas las opiniones expresadas en las historias de 91ÊÓÆµ News reflejan la posición oficial de la 91ÊÓÆµ. Las declaraciones, las conclusiones, la precisión y veracidad de los estudios publicados en revistas científicas de la 91ÊÓÆµ o presentados en reuniones científicas de la 91ÊÓÆµ son solo de los autores del estudio y no reflejan necesariamente la orientación, las políticas o las posiciones oficiales de la 91ÊÓÆµ.

Los derechos de autor pertenecen a la 91ÊÓÆµ, Inc. y están reservados todos los derechos. Se concede permiso, sin ningún costo y sin necesidad de realizar una solicitud adicional, a las personas, medios de comunicación y esfuerzos de educación y concientización no comerciales para vincular, citar, extraer o reimprimir estas historias en cualquier medio, a condición de que no se modifique el texto y se haga la referencia adecuada a 91ÊÓÆµ News.

Otros usos, incluidos productos o servicios educativos que se venden con fines de lucro, deben cumplir con las Directrices para el permiso de los derechos de autor de la 91ÊÓÆµ. Consulta los términos de uso completos. Estas historias no pueden usarse para promover o respaldar un producto o servicio comercial.

DESCARGO DE RESPONSABILIDAD SOBRE CUIDADO DE LA SALUD: Este sitio y sus servicios no constituyen una recomendación médica, un diagnóstico ni un tratamiento. Siempre consulte a un profesional de la salud para el diagnóstico y el tratamiento, lo que incluye sus necesidades médicas específicas. Si tiene o sospecha que tiene algún problema o afección médica, comuníquese inmediatamente con un profesional de la salud calificado. Si te encuentras en Estados Unidos y tienes una emergencia médica, llama al 911 o al número de emergencia local, o solicita ayuda médica de emergencia de inmediato.